SEMA6B Activators
SEMA6B Activators belongs to a group of compounds that primarily target the SEMA6B protein, a member of the semaphorin family. SEMA6B is a transmembrane protein that plays a significant role in axon guidance, neuronal development, and cell adhesion processes within the nervous system. Activators of SEMA6B are molecules designed to modulate the activity of this protein, typically by binding to specific binding sites or receptors on its surface.
These activators can have diverse chemical structures and mechanisms of action, but their commonality lies in their ability to influence SEMA6B-mediated signaling pathways. By doing so, they can potentially impact neuronal growth cone guidance, neuronal migration, and cellular interactions in various contexts. Researchers are interested in understanding the intricate details of SEMA6B activation as it may have implications in fundamental neurobiology and cellular processes. Unraveling the mechanisms behind SEMA6B activation could provide valuable insights into neural development and may indirectly contribute to our understanding of certain neurological disorders or conditions where SEMA6B is involved. It is important to note that further research is needed to elucidate the full scope of SEMA6B activators and their potential relevance beyond basic cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin raises intracellular cAMP levels, which in turn can activate PKA. PKA phosphorylation targets may include components of the cytoskeleton or intracellular trafficking machinery, potentially influencing SEMA6B's guidance of axonal growth. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts via its receptors to influence cytoskeletal rearrangements and cell migration, processes in which SEMA6B is implicated. This could enhance SEMA6B's role in neural patterning and axon guidance. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits phosphodiesterase 4, thereby preventing cAMP breakdown and enhancing PKA activity. This can indirectly promote SEMA6B-mediated signaling by influencing cAMP-dependent pathways within the nervous system. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate inhibits kinases involved in negative regulation of axon guidance pathways. By inhibiting these kinases, SEMA6B's axonal guidance activity could be indirectly enhanced by reducing competitive signaling. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Lysophosphatidic acid, through its receptors, can modulate the actin cytoskeleton and cell morphology. This may indirectly boost SEMA6B's functional activity by impacting the cellular structures SEMA6B interacts with during neural development. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can lead to cytoskeletal rearrangements, thereby potentially enhancing SEMA6B's influence on axon guidance and neuronal patterning by modulating the physical substrates of SEMA6B's action. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C, which can affect numerous substrates related to cytoskeletal rearrangement and cell adhesion, potentially enhancing SEMA6B's role in axonal pathfinding by altering the intracellular signaling milieu. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide inhibits phosphodiesterase 3, increasing cAMP levels, which may bolster the activity of PKA and other cAMP-responsive elements, potentially amplifying SEMA6B's signaling in neuronal development and axon guidance. | ||||||
Latrunculin B | 76343-94-7 | sc-203318 | 1 mg | $240.00 | 29 | |
Latrunculin B disrupts actin polymerization, leading to changes in cell shape and motility. This actin disruption could enable SEMA6B to have an increased role in directing neuronal growth by influencing the actin cytoskeleton's dynamics. | ||||||